These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15292687

  • 1. Proatrial natriuretic peptide (1-98), but not cystatin C, is predictive for occurrence of acute renal insufficiency in critically ill septic patients.
    Mazul-Sunko B, Zarković N, Vrkić N, Antoljak N, Bekavac Beslin M, Nikolić Heitzler V, Siranović M, Krizmanić-Dekanić A, Klinger R.
    Nephron Clin Pract; 2004; 97(3):c103-7. PubMed ID: 15292687
    [Abstract] [Full Text] [Related]

  • 2. Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients.
    Mårtensson J, Martling CR, Oldner A, Bell M.
    Nephrol Dial Transplant; 2012 Feb; 27(2):576-81. PubMed ID: 21765189
    [Abstract] [Full Text] [Related]

  • 3. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients.
    Villa P, Jiménez M, Soriano MC, Manzanares J, Casasnovas P.
    Crit Care; 2005 Apr; 9(2):R139-43. PubMed ID: 15774046
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cystatin C as a marker of residual renal function during continuous hemodiafiltration.
    Balík M, Jabor A, Waldauf P, Kolár M, Pavlisová M, Brest'an D, Hendl J, Rychlík I.
    Kidney Blood Press Res; 2005 Apr; 28(1):14-9. PubMed ID: 15377821
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
    Linzbach S, Samigullin A, Yilmaz S, Tsioga M, Zeiher AM, Spyridopoulos I.
    Am J Cardiol; 2009 Apr 15; 103(8):1128-33. PubMed ID: 19361601
    [Abstract] [Full Text] [Related]

  • 8. Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients.
    Berdal JE, Stavem K, Omland T, Hall C, Smith-Erichssen N.
    Acta Anaesthesiol Scand; 2008 Oct 15; 52(9):1265-72. PubMed ID: 18823467
    [Abstract] [Full Text] [Related]

  • 9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T, Takeishi Y, Niizeki T, Takabatake N, Okuyama H, Fukui A, Tachibana H, Nozaki N, Hirono O, Tsunoda Y, Miyashita T, Shishido T, Takahashi H, Koyama Y, Kubota I.
    J Card Fail; 2005 Oct 13; 11(8):595-601. PubMed ID: 16230262
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.
    Am J Cardiol; 2009 Jun 15; 103(12):1753-9. PubMed ID: 19539088
    [Abstract] [Full Text] [Related]

  • 14. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
    Delaney MP, Stevens PE, Al Hasani M, Stowe HJ, Judge C, Lamb EJ.
    Am J Kidney Dis; 2008 Feb 15; 51(2):278-84. PubMed ID: 18215705
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C, Morange S, Portugal H, Berland Y, Dussol B.
    Am J Kidney Dis; 2001 Aug 15; 38(2):310-6. PubMed ID: 11479157
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
    Melander O, Frandsen E, Magnusson M, Grubb A, Jovinge S, Groop L.
    J Intern Med; 2005 Mar 15; 257(3):281-8. PubMed ID: 15715685
    [Abstract] [Full Text] [Related]

  • 19. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H, Ishii J, Kawai T, Hattori K, Ishikawa M, Okumura M, Kan S, Nakano T, Matsui S, Nomura M, Hishida H, Ozaki Y.
    Am J Med; 2009 Jun 15; 122(6):566-73. PubMed ID: 19393984
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.